measles
DESCRIPTION
MEASLES. RUBEOLA OR MORBILLI. DEFINITION. Measles is an acute highly contagious viral disease caused by measles virus.It is characterized by fever,URT catarrhal inflamation, koplik’s spots and ulemaculopaps. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/1.jpg)
MEASLES
RUBEOLA OR MORBILLI
![Page 2: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/2.jpg)
DEFINITION• Measles is an acute highly contagious viral
disease caused by measles virus.It is characterized by fever,URT catarrhal inflamation, koplik’s spots and ulemaculopaps.
• The disease may complicated with branch- pneumonia, encephalitis, hepatitis.
• The lived attenuated measles virus vaccine has been utilized wildly since 1965 ,the incidence of the disease has declined in china.
![Page 3: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/3.jpg)
ETIOLOGY• 1 .Pathogen is measles virus.
it has been classed as a paramyxovirus.it is spherical in appearance ,measuring about 100~150nm in diameter.It has an outer envelope composed of M-protein, H-protein, F-protein, and internal core is RNA.
• 2 .Site of the measles virus exists
measles can be detected from blood and nasal, pharyngeal secretions.
![Page 4: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/4.jpg)
`
• 3. Three kinds of antibodies are produced after infection,that is
• 3.1 complement combining antibody;
• 3.2 hemagglutinin inhibiting antibody
• 3.3 neutralizing antibody
• 4 .Only one antigenic type of measles virus
• is known.
• 5.Resistance:measles virus is sensitive to
heat or disinfectant , it is also inactivated by ultraviolet light easily. not strong
![Page 5: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/5.jpg)
EPIDEMIOLOGY• 1.Source of infection The patients are the only source of infection. • 2 .Routes of transmission air-borne• 3. Susceptibility of population 3.1 All age person is susceptible; 90% of
contact people acquire the disease. 3.2 The permanent immunity acquire after
disease.• 4. Epidemic features season:winter and spiring age:6 months to 5 years old
![Page 6: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/6.jpg)
PATHOLOGY
• Rash: corium superficial blood vessel• Pigmentation:• Desquamation:• Koplik’s spots
![Page 7: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/7.jpg)
CLINICAL MANIFESTATIONS• Typical type
• 1.Incubation period is approximately 6~18days,10days is the most common.
(3-4weeks)• 2 .predromal phase 3~4 days. 2 .1 Fever; 2 .2 Catarrhal inflammation of URT; 2 .3 Koplik’s spots; 2 .4 Transient prodromal rashes.
yy:yy:
![Page 8: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/8.jpg)
• 3. Eruption stage 3 .1. Time: the3~5 days after fever;but the 4th
day is most common; 3 .2 . Shape:maculopapular 3.3. Sequence:behind the ear→along the
hairline→face→neck→chest→back→abdomen→limbs→hand and fee.
3 .4 . The temperature rise continuously and companied with the toxic symptoms
• 4 . Convalescent stage brown staining. fine branny desquamation. course:10-14 days
![Page 9: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/9.jpg)
• Atypical measles
1 . mild measles;
2 . severe measles (toxic and shock type measles);
3. hemorrhagic measles;
4 . variant measles.
![Page 10: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/10.jpg)
COMPLICATIONS• 1 .Bronchopneumonia;• 2 .Myocarditis;• 3 .Laryngitis;• 4 .Neurologic complications: Encephalitis
![Page 11: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/11.jpg)
![Page 12: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/12.jpg)
![Page 13: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/13.jpg)
![Page 14: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/14.jpg)
LABORATORY FINDINGS• Blood routine• Serum Ab measurement
complement combining antibody;
hemagglutinin inhibiting antibody;
neutralizing antibody;
specific antibody IgM.• Other Ag and multinucleated giant cells
![Page 15: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/15.jpg)
Diagnosis:Diagnosis:•Diagnosis is usually clinical.•Multinucleated giant cells are detected in nasopharynx mucosa secretions.•Virus isolation: •Resp secretion•Buffy coat•urine
•RT-PCR•Serology: commonly used technique. Specific IgM
![Page 16: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/16.jpg)
DIFFERENTIAL DIAGNOSIS
• 1 .Rubella (German measles) ;• 2 .Roseola infantum (infant
subitum,exanthem subitum)• 3. Drug rashes.*the early stage definite diagnosis is:*the early stage clinical diagnosis is: *the clinical diagnosis is:
![Page 17: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/17.jpg)
treatment
• 1 .General therapy: rest, nursing and diet
• 2. Symptomatic therapy: fever and cough,
• 3.Support threapy:r-globulin traditional chinese herbs may be
used ;• 4.complications of treatment
![Page 18: MEASLES](https://reader036.vdocument.in/reader036/viewer/2022070401/5681368e550346895d9e1910/html5/thumbnails/18.jpg)
PREVENTION• 1 .Control source of infection;• 2 .Interruption of transmissions ;• 3 .Protection of the susceptible person: 3.1 . Active immunization Lived attenuated measles vaccine.3.2 . Passive immunization placenta globulin or gamma globulin.